Gimeno Hernán, VerónicaPeix Jiménez, BelénPérez Flores, Isabel MaríaAiffil Meneses, ArrianneOrtuño Soriano, IsmaelSánchez Fructuoso, Ana Isabel2025-03-202025-03-202024-06-30Gimeno-Hernán V, Peix-Jiménez B, Pérez-Flores I, Aiffil-Meneses A, Ortuño-Soriano I, Sánchez-Fructuoso A. Incidence of adverse events of the Covid-19 vaccine in a population of kidney transplant recipients. Enfermeria Nefrologica. 2024;27(2):119-25.2255-35172254-288410.37551/s2254-28842024013https://hdl.handle.net/20.500.14352/118880Introducción: Early published series suggest that most renal transplant recipients remain at high risk of SARS-CoV-2 infection due to poor humoral response after vaccination. The aim was to study the occurrence of adverse events after two doses of mRNA-1273 vaccine in a population of renal transplant recipients. Material and Method: Analytical, observational, and prospective study. Subjects were injected with two doses of mRNA-1273 vaccine against SARS-CoV-2 according to the schedule established by the laboratory. After injection of each dose, and up to 72 hours later, participants recorded local and/or systemic symptoms and their intensity. Results: 187 patients were included. Eighteen percent of them became infected with SARS-CoV-2 in the pre-vaccination period or between the 1st and 2nd dose. The incidence of adverse events was 91.2%. Of these, the incidence of local (62%) was higher than that of systemic (55%). Past infection was a risk factor for the occurrence of local adverse events after vaccination (OR= 2.4; p=0.045). The same association was detected for systemic adverse events, which were more frequent among those who had passed the disease (OR=3.83; p=0.003). Conclusions: The mRNA-1273 vaccine does not appear to cause serious side effects. The incidence of local and systemic adverse events was higher in those patients with past disease.engAttribution-NonCommercial 4.0 Internationalhttp://creativecommons.org/licenses/by-nc/4.0/journal articlehttps://doi.org/10.37551/S2254-28842024013https://enfermerianefrologica.com/revista/article/view/4758/1830open access61Renal transplantationmRNA-1273 vaccineSARS-CoV-2 adverse reactionsCiencias Biomédicas3299 Otras Especialidades Médicas